Your browser doesn't support javascript.
loading
Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML.
Stasik, Sebastian; Burkhard-Meier, Clara; Kramer, Michael; Middeke, Jan M; Oelschlaegel, Uta; Sockel, Katja; Ehninger, Gerhard; Serve, Hubert; Müller-Tidow, Carsten; Baldus, Claudia D; Röllig, Christoph; Bornhäuser, Martin; Platzbecker, Uwe; Thiede, Christian.
Afiliación
  • Stasik S; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.
  • Burkhard-Meier C; German Cancer Consortium (DKTK), Dresden, Germany.
  • Kramer M; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.
  • Middeke JM; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.
  • Oelschlaegel U; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.
  • Sockel K; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.
  • Ehninger G; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.
  • Serve H; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.
  • Müller-Tidow C; Department of Medicine II, Hematology and Oncology, Goethe University Frankfurt, Frankfurt, Germany.
  • Baldus CD; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Röllig C; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Bornhäuser M; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.
  • Platzbecker U; Medical Department I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.
  • Thiede C; National Center for Tumor Diseases (NCT), Dresden, Germany.
Blood Adv ; 6(11): 3294-3303, 2022 06 14.
Article en En | MEDLINE | ID: mdl-35320339
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Alemania